Physician profile
Christopher Bacak
NPI 1548904022
$2,346.93
in general payments reported to CMS, 2019-2025
14 companies · $1,456 in 2025
The $1,456 reported for 2025 was more than what 91% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $21.06 · 2023: $338 · 2024: $532 · 2025: $1,456.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,325.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,288.86 | 2023-2025 | Pangea, Gmrs, Aequalis Perform Reversed |
| Zimmer Biomet Holdings, INC. | $283.20 | 2023-2025 | Persona, Taperloc, Xtrafix |
| Vericel Corporation | $248.71 | 2024-2025 | Maci |
| Si-Bone, INC. | $95.16 | 2023-2024 | |
| Sanara Medtech INC. | $69.27 | 2025 | Celleraterx |
| Vertex Pharmaceuticals Incorporated | $67.31 | 2025 | |
| Kci USA, INC. | $56.78 | 2022-2023 | V.A.C. Veraflo, Prevena |
| Orthofix Medical, INC. | $55.46 | 2024-2025 | Ankle Hindfoot Nailing System, Truelok |
| Linvatec Corporation | $51.59 | 2023 | Biobrace 23mm |
| Rattan and Associates | $49.10 | 2025 | |
| Bioventus LLC | $22.93 | 2025 | Durolane |
| Pacira Pharmaceuticals Incorporated | $21.60 | 2025 | Exparel |
| Convatec INC. | $20.14 | 2025 | |
| Csl Behring | $16.82 | 2023 | Kcentra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Bacak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.